Peabody Reports Results for the Quarter Ended June 30, 2026

Peabody’s Q2 2026 loss deepens as margins shrink and cash burn accelerates.

What the company is saying

Peabody frames the quarter as transitional, highlighting operational progress at Centurion and projecting improved results in the second half of 2026. The announcement emphasizes liquidity strength, citing $526.3 million in cash and $959.1 million in total liquidity as of June 30, 2026. Management claims significant capital actions, including issuing $250 million of 2031 convertible notes, repurchasing $241.2 million of 2028 notes for $386.8 million, and reducing reclamation collateral by $350 million. The company points to a declared $0.075 per share dividend and a grant from the U.S. Department of Energy for rare earth and critical minerals as evidence of strategic progress. Forward-looking statements focus on Centurion’s targeted 1.5–2.0 million tons of sales and anticipated strong cash generation in the second half. The tone remains measured, with no overt optimism or promotional language, but operational milestones and grant details are presented without supporting numbers.

What the data suggests

The numbers show a sharp deterioration in profitability. Net income attributable to common stockholders fell to $(90.6) million for Q2 2026, down from $(27.6) million a year earlier, and diluted EPS dropped to $(0.74) from $(0.23). Adjusted EBITDA declined to $24.0 million from $93.3 million, indicating a significant margin squeeze. Revenue for the quarter was $1,003.2 million, but high operating costs and expenses of $953.9 million, plus $107.5 million in depreciation, left little room for profit. Liquidity remains robust at $959.1 million, but this is partly sustained by new debt issuance and asset sales, not operational cash flow. The company’s capital actions—issuing $250 million in new notes and repurchasing $241.2 million of old notes for $386.8 million—signal balance sheet management rather than growth. Operational claims about Centurion and the DOE grant lack numerical backing, and there is no evidence of realised turnaround in the reported period.

Analysis

The announcement's tone is measured and factual, with no evidence of narrative inflation or exaggerated claims. The majority of key claims are realised and supported by numerical data, including net income, EBITDA, and liquidity metrics. Forward-looking statements (such as targeted sales at Centurion and anticipated cash generation) are limited and presented as near-term operational goals rather than aspirational projections. There is no promotional language or overstatement of future benefits, and the company openly discloses a deterioration in profitability. Capital outlays (such as note issuance and repurchases) are matched by immediate balance sheet actions, not long-dated, uncertain returns. The gap between narrative and evidence is minimal, and the data supports a weak negative signal due to declining financial performance, not due to hype.

Risk flags

• ●Profitability risk is acute, as net income and EBITDA have both sharply declined year-over-year, with Q2 2026 net loss at $(90.6) million and EBITDA at $24.0 million. This trend, if sustained, threatens both capital returns and operational flexibility.
• ●Operational execution risk centers on Centurion, where the company claims longwall commissioning is complete and targets 1.5–2.0 million tons of sales in H2 2026, but provides no evidence of ramp-up or cost control. Failure to deliver these volumes or margins would further pressure results.
• ●Disclosure risk is present: non-GAAP measures like Adjusted EBITDA are not reconciled to GAAP, and key claims—such as the DOE grant and Centurion’s operational progress—lack supporting numerical detail. This limits transparency and makes it difficult to independently validate management’s narrative.

Bottom line

This is a weak quarter for Peabody, with profitability deteriorating and cash flow under pressure despite headline liquidity. Management’s narrative relies on near-term operational improvements at Centurion and capital structure maneuvers, but the evidence for a turnaround is not yet visible in the numbers. The absence of detail on the DOE grant and Centurion’s actual ramp-up raises questions about the achievability of second-half targets. Investors should focus on whether H2 2026 delivers the promised production, margin, and cash improvements. Until operational gains are realized and disclosed with supporting data, the most important takeaway is that Peabody remains in a defensive posture, not a growth trajectory.

Announcement summary

(NYSE: BTU) Peabody reported net income attributable to common stockholders of $(90.6) million, or $(0.74) per diluted share, for the second quarter of 2026, compared to $(27.6) million, or $(0.23) per diluted share, in the prior-year quarter. Adjusted EBITDA for the second quarter of 2026 was $24.0 million, down from $93.3 million in the prior-year quarter. The company completed significant longwall commissioning activities at Centurion and is targeting 1.5 to 2.0 million tons of sales in the second half of 2026. Peabody issued $250 million of 0.5% 2031 convertible notes, repurchased $241.2 million of 3.25% 2028 convertible notes for cash consideration of $386.8 million, and reduced reclamation cash collateral requirements by approximately $350 million. At June 30, 2026, the company had $526.3 million cash and total liquidity of $959.1 million. The company projects improved results in the second half of the year as Centurion Mine achieves targeted production rates and is targeting strong cash generation for the second half of 2026.

Disagree with this article?